Afrigen Biologics and Vaccines is a South African pharmaceutical company. Afrigen developed a COVID vaccine and is working on mRNA vaccines for tuberculosis and HIV.[1][2][3] It is based in the City of Cape Town Metropolitan Municipality.[4]